欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0242/001
药品名称Maymetsi 50 mg/850 mg film-coated tablets
活性成分
    • Metformin hydrochloride 850.0 mg
    • Sitagliptin 50.0 mg
剂型Film-coated tablet
上市许可持有人Krka, d.d., Novo mesto Smarjeska cesta 6 8501 Slovenia
参考成员国 - 产品名称Slovakia (SK)
Maysiduo 50 mg/ 850 mg
互认成员国 - 产品名称
    • Hungary (HU)
      Maymetsi 50 mg/850 mg filmtabletta
    • Bulgaria (BG)
      Maysiduo
    • Cyprus (CY)
      Maysiduo 50 mg/850 mg film-coated tablet
    • Czechia (CZ)
      Maysiduo
    • Romania (RO)
    • Slovenia (SI)
      Maymetsi 50 mg/850 mg filmsko obložene tablete
    • Croatia (HR)
      Maymetsi 50 mg/850 mg filmom obložene tablete
    • Greece (GR)
    • Poland (PL)
      Maysiduo
    • Latvia (LV)
      Maymetsi 50 mg/850 mg apvalkotās tabletes
    • Lithuania (LT)
      MAYMETSI 50 mg/850 mg plėvele dengtos tabletės
    • Estonia (EE)
      MAYMETSI
许可日期2020/11/19
最近更新日期2024/11/13
药物ATC编码
    • A10BD07 metformin and sitagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase